FDA
label_change
· 2022-02-25
FDA Approved: CYSTARAN — Supplemental Application (Leadiant Biosciences, Inc.)
Summary
FDA approved a supplemental application for Cystaran (cysteamine hydrochloride) from Leadiant Biosciences, Inc. The action involves changes to the product label…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CYSTARAN (CYSTEAMINE HYDROCHLORIDE)